Stage IIA lung non-small cell carcinoma ajcc V7

Clinical trials for Stage IIA lung non-small cell carcinoma ajcc V7 explained in plain language.

Never miss a new study

Get alerted when new Stage IIA lung non-small cell carcinoma ajcc V7 trials appear

Sign up with your email to follow new studies for Stage IIA lung non-small cell carcinoma ajcc V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 2

Targeted pill may keep EGFR lung cancer from returning after surgery

Disease control Ongoing

This phase 3 trial tests whether taking erlotinib (Tarceva) after surgery helps people with EGFR-mutant non-small cell lung cancer live longer and stay cancer-free longer. About 390 patients who had their lung cancer completely removed are randomly assigned to receive erlotinib p…

Matched conditions: STAGE IIA LUNG NON-SMALL CELL CARCINOMA AJCC V7

Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC

Stage IIA lung non-small cell carcinoma ajcc V7

Get alerted when new Stage IIA lung non-small cell carcinoma ajcc V7 trials appear

Targeted pill may keep EGFR lung cancer from returning after surgery